RHYTHM PHARMACEUTICALS, INC. (RYTM) › Total LiabilitiesRHYTHM PHARMACEUTICALS, INC. (RYTM) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2016: $5.04M2017: $6.95M2018: $13.95M2019: $27.50M2020: $20.55M2021: $45.37M2022: $118.22M2023: $162.99M2024: $227.72M2025: $210.17M$210.17M2016Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$210.17M-7.7%2024$227.72M+39.7%2023$162.99M+37.9%2022$118.22M+160.6%2021$45.37M+120.8%2020$20.55M-25.3%2019$27.50M+97.1%2018$13.95M+100.8%2017$6.95M+37.8%2016$5.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share